The ARC Digital Bioprocess Development Hub (DBD Hub) is a five-year collaborative program that brings together leading researchers and industry partners to help revolutionise Australia’s biopharmaceutical manufacturing sector.
The Hub is focused on enhancing digital innovation, boosting productivity, and increasing competitiveness by developing digitally integrated advanced manufacturing processes and creating a platform for industry-wide adoption.
Latest News
9 October 2026
Adding Low-Fidelity Data to ML Training Sets Could Yield Better Process Models
This article in Genetic Engineering & Biotechnology News covers our work within the ARC Digital Bioprocess Development Hub, where we are exploring…
13 February 2026
Doing More with Less: Multifidelity Optimization in the Biopharmaceutical Industry
Multifidelity optimization combines inexpensive, approximate data with results from limited numbers of high-quality experiments by modifying a…
19 September 2025
DBD Hub PhD Student wins BioProcessing Network Conference Award
Kauthar Maalim, PhD student from the ARC Digital Bioprocess Development Hub wins Student poster award at BioProcessing Network conference.
14 October 2024
Two DBD Hub PhD Students win BioProcessing Network Conference Awards
Two PhD students from the ARC Digital Bioprocess Development Hub have received BioProcessing Network Conference Awards in Brisbane, Australia.
Our People
The team at the DBD Hub consists of interdisciplinary experts combining biotechnology, data science and engineering to innovate and optimise processes in biopharmaceutical production.
Click to read more.








